Omada Health (OMDA) CFO sells 17,950 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

Omada Health, Inc. Chief Financial Officer Steven L. Cook sold 17,950 shares of common stock in an open-market transaction at a weighted average price of $18.1278 per share. Following this sale, he directly holds 169,259 shares. The trade was made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026.

Insider Trade Summary 10b5-1

Net Seller: 17,950 shares ($325,394)

Net Sell 1 txn

Insider Cook Steven L.

Role Chief Financial Officer

Sold 17,950 shs ($325K)

Type	Security	Shares	Price	Value
Sale	Common Stock	17,950	$18.1278	$325K

Holdings After Transaction: Common Stock — 169,259 shares (Direct, null)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. This transaction was executed in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 17,950 shares Weighted average sale price: $18.1278 per share Post-transaction holdings: 169,259 shares +3 more

6 metrics

Shares sold 17,950 shares Open-market sale of common stock

Weighted average sale price $18.1278 per share Common stock sale on June 22, 2026

Post-transaction holdings 169,259 shares CFO’s direct ownership after the sale

Trade price range $18.00–$18.30 Range of prices for multiple executed trades

Trading plan adoption date March 14, 2026 Date Rule 10b5-1 plan was adopted

Transaction code S Sale in open market or private transaction

Key Terms

Rule 10b5-1 trading plan, weighted average price, open-market sale, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported above reflects the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/24/2026 - 04:19 PM Accepted by SEC EDGAR 06/24/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/22/2026		S(1)		17,950	D	$18.1278(2)	169,259	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

2. This transaction was executed in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Omada Health (OMDA) report for Steven L. Cook?

Omada Health reported that CFO Steven L. Cook sold 17,950 shares of common stock in an open-market transaction at a weighted average price of $18.1278 per share, leaving him with direct ownership of 169,259 shares after the sale.

At what price did the Omada Health (OMDA) CFO sell his shares?

The CFO’s sale was executed at a weighted average price of $18.1278 per share, with individual trades occurring in a price range from $18.00 to $18.30, as disclosed in the transaction’s detailed footnote description.

How many Omada Health (OMDA) shares does the CFO hold after this Form 4 sale?

After selling 17,950 shares, Omada Health CFO Steven L. Cook directly holds 169,259 shares of the company’s common stock, according to the post-transaction ownership figure reported in the Form 4 filing with the SEC.

Was the Omada Health (OMDA) CFO’s share sale under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Steven L. Cook on March 14, 2026, indicating the sale was pre-arranged rather than an opportunistic market-timing decision.

What type of transaction was reported in Omada Health (OMDA) CFO’s Form 4?

The Form 4 describes an open-market sale of common stock, coded as “S,” meaning a sale in the open market or a private transaction, with no associated option exercises or derivative security conversions reported in this filing.